Invention Grant
- Patent Title: Anti-OX40L antibodies
- Patent Title (中): 抗OX40L抗体
-
Application No.: US12315863Application Date: 2008-12-05
-
Publication No.: US07868141B2Publication Date: 2011-01-11
- Inventor: Joseph Endl , Elsie M. Eugui , Maria Elena Fuentes , Yvo Graus , Aran Frank Labrijn , Martin Lanzendoerfer , Paul Parren , Frank Rebers , Ralf Schumacher , Stefan Seeber , Jan Van De Winkel , Martine Van Vugt
- Applicant: Joseph Endl , Elsie M. Eugui , Maria Elena Fuentes , Yvo Graus , Aran Frank Labrijn , Martin Lanzendoerfer , Paul Parren , Frank Rebers , Ralf Schumacher , Stefan Seeber , Jan Van De Winkel , Martine Van Vugt
- Applicant Address: US CA Palo Alto
- Assignee: Roche Palo Alto LLC
- Current Assignee: Roche Palo Alto LLC
- Current Assignee Address: US CA Palo Alto
- Agent Robert C. Hall
- Priority: EP04022158 20040917; EP04030546 20041223
- Main IPC: C07K16/00
- IPC: C07K16/00 ; A61K39/395
Abstract:
This invention relates to anti-OX40L antibodies and, in particular, to anti-OX40L antibodies and variants thereof that contain a Fc part derived from human origin and do not bind complement factor C1q. These antibodies have new and inventive properties causing a benefit for a patient suffering from inflammatory diseases.
Public/Granted literature
- US20100166740A1 Anti-OX40L antibodies Public/Granted day:2010-07-01
Information query
